The Purinergic Receptor Subtype P2Y2 Mediates Chemotaxis of Neutrophils and Fibroblasts in Fibrotic Lung Disease

Oncotarget - United States
doi 10.18632/oncotarget.16414
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

The Regulation of Skin Fibrosis in Systemic Sclerosis by Extracellular ATP via P2Y2 Purinergic Receptor

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

P53 Expression in Lung Fibroblasts Is Linked to Mitigation of Fibrotic Lung Remodeling

American Journal of Pathology
Forensic MedicinePathology
2018English

Heterogeneity of Fc Receptor Expression in Chemotaxis and Adherence of Neonatal Neutrophils

Pediatric Research
Child HealthPediatricsPerinatology
1989English

Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis

Clinical Cancer Research
Cancer ResearchOncology
2018English

microRNA-29b Mediates Fibrotic Induction of Human Xylosyltransferase-I in Human Dermal Fibroblasts via the Sp1 Pathway

Scientific Reports
Multidisciplinary
2018English

Neutrophils, Interleukin-17a and Lung Disease

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2005English

P2X Receptor-Mediated ATP Purinergic Signaling in Health and Disease

Cell Health and Cytoskeleton
BiochemistryCell BiologyStructural BiologyHistology
2012English

Bruton’s Tyrosine Kinase Mediates FcγRIIa/Toll-Like Receptor–4 Receptor Crosstalk in Human Neutrophils

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2013English

A PilZ-Containing Chemotaxis Receptor Mediates Oxygen and Wheat Root Sensing in Azospirillum Brasilense

Frontiers in Microbiology
Microbiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy